FDA allows standalone use of nasal spray antidepressant Spravato (esketamine)
The U.S. Food and Drug Administration has expanded its approval of Spravato, an antidepressant nasal spray. The drug is now cleared for use as a standalone treatment for depression.
Spravato is made from esketamine, one of two mirror-image molecules found in the anesthetic ketamine. It was approved in 2019 for use in adults with major depressive disorder who did not respond to at least two other antidepressants.
The original approval required that patients on Spravato also receive an oral antidepressant. Now, the FDA says the drug can be used on its own. The decision came after a large study found that Spravato alone worked better than a placebo. In the first nine months of 2024, the drug generated sales of about $780 million for its maker, Johnson & Johnson.
Spravato is intended to be administered under the direct supervision of a healthcare provider.
In the company’s press release announcing the expanded use, it stressed that depression is complicated and the drug could cause, “serious adverse outcomes resulting from sedation, dissociation, respiratory depression, abuse, and misuse,” so it will continue to be administered in certified treatment centers.
Major depressive disorder affects more than 20 million adults in the U.S. About one in three patients does not respond to oral antidepressants alone.
How a firefighter’s quick action saved his friend’s life
Ronald Osborne was a firefighter for many years. Early in his career, while battling a house fire, his life was in danger. It was another firefighter's quick thinking that saved him.
A law in New York pushes doctors to be upfront about patients’ costs
The law originally banned health care providers from forcing patients to agree to pay medical bills, no matter the cost. Consumer groups say an amended version doesn't go far enough.
Attorneys, advocates make last-minute bid to stop Louisiana’s execution of Jessie Hoffman
Hoffman’s execution is set for Tuesday after the Fifth Circuit Court of Appeals overturned a federal judge’s decision to block it earlier this month.
No. 1 seed Auburn has a roster filled with ‘underdog kids’ looking for a turnaround in NCAA play
Auburn has an unusual roster makeup for an overall No. 1 seed in the NCAA Tournament and the Southeastern Conference’s regular-season champion — even in the topsy-turvy, transfer-friendly world of college sports.
Heat can age you as much as smoking, a new study finds
Exposure to heat can alter the way your DNA works, according to a new study. The effects could lead to long-term health outcomes.
Her cancer diagnosis made motherhood both harder and more sweet
As cancer rates rise among people under 50, more and more parents are facing the heightened emotions and challenging logistics of raising kids while going through treatment.
